See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for David Lillicrap

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	39970990	0	Underwood M, Da Veiga Leprevost F, Basrur V, et al. Identification of multiple novel procoagulant plasma ligands for stabilin-2. J Thromb Haemost. 2025 Feb 17:S1538-7836(25)00106-0. doi: 10.1016/j.jtha.2025.01.023.
	39642092	0	Albisetti M, Ardila J, Astermark J, et al. International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal. Haemophilia. 2024 Dec 6. doi: 10.1111/hae.15135.
	38381848	0	Strilchuk AW, Hur WS, Batty P, et al. Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A. Sci Transl Med. 2024 Feb 21;16(735):eadh0027. doi: 10.1126/scitranslmed.adh0027. Epub 2024 Feb 21.
	37085036	0	Swystun LL, Michels A, Lillicrap D. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis. J Thromb Haemost. 2023 Apr 19:S1538-7836(23)00332-X. doi: 10.1016/j.jtha.2023.04.014.
	36696220	0	Choi SJ, Dwyer CN, Rapkin L, et al. The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in mice. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07636-X. doi: 10.1016/j.jtha.2022.11.022.
	35780487	0	Lavin M, Christopherson P, Grabell J, et al. Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score. J Thromb Haemost. 2022 Jul 3. doi: 10.1111/jth.15807.
	35445575	0	Lillicrap D, Morrissey JH. Investment in the future of thrombosis and hemostasis science. J Thromb Haemost. 2022 May;20(5):1033. doi: 10.1111/jth.15710.
	35028601	0	Michels A, Lillicrap D, Yacob M. Role of von Willebrand factor in venous thromboembolic disease. JVS Vasc Sci. 2021 Oct 7;3:17-29. doi: 10.1016/j.jvssci.2021.08.002. eCollection 2022.
	34649864	0	Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400.
	34351057	0	Othman M, Baker AT, Gupalo E, et al. To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia. J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485. Epub 2021 Aug 23.
	34327823	0	Lillicrap D, Morrissey JH. Evidence-based medicine in thrombosis and hemostasis: ISTH to the fore. J Thromb Haemost. 2021 Aug;19(8):1845-1846. doi: 10.1111/jth.15436.
	34288447	0	Batty P, Lillicrap D. Gene therapy for hemophilia: Current status and laboratory consequences. Int J Lab Hematol. 2021 Jul;43 Suppl 1:117-123. doi: 10.1111/ijlh.13605.
	34152080	0	Michels A, Swystun LL, Dwyer CN, et al. Stabilin-2 deficiency increases thrombotic burden and alters the composition of venous thrombi in a mouse model. J Thromb Haemost. 2021 Oct;19(10):2440-2453. doi: 10.1111/jth.15429. Epub 2021 Jul 19.
	33691765	0	Sholzberg M, Tang GH, Negri E, et al. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
	33506480	0	Blanchette VS, Zunino L, Grassmann V, et al. A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects. Thromb Haemost. 2021 Oct;121(10):1326-1336. doi: 10.1055/a-1376-0970. Epub 2021 Jan 27.
	33410894	0	Abrams ST, Su D, Sahraoui Y, et al. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood. 2021 Jan 7;137(1):103-114. doi: 10.1182/blood.2019002973.
	33170819	0	Lillicrap D. Evaluating the potential benefits of the extravascular pool of factor IX. Blood Coagul Fibrinolysis. 2021 Jan 1;32(1):68-69. doi: 10.1097/MBC.0000000000000969.
	32967458	0	Michels A, Dwyer CN, Mewburn J, et al. von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity. Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2860-2874. doi: 10.1161/ATVBAHA.120.314690. Epub 2020 Sep 24.
	32881334	0	Lillicrap D, Morrissey JH. 2020 - Year of COVID-19. J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041.
	31999061	0	Lillicrap D, Morrissey JH. Hemostasis and thrombosis 101-A challenge to energize. J Thromb Haemost. 2020 Feb;18(2):269. doi: 10.1111/jth.14731.
	31479183	0	Lillicrap D, Morrissey JH. Genomic momentum for hemostasis and thrombosis. J Thromb Haemost. 2019 Sep;17(9):1411. doi: 10.1111/jth.14582.
	31404933	0	Ghorbanpour E, Lillicrap D. Innovative Molecular Testing Strategies for Adjunctive Investigations in Hemostasis and Thrombosis. Semin Thromb Hemost. 2019 Oct;45(7):751-756. doi: 10.1055/s-0039-1692977. Epub 2019 Aug 12.
	31350267	0	Swystun LL, Ogiwara K, Rawley O, et al. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients. Blood. 2019 Sep 12;134(11):880-891. doi: 10.1182/blood.2019000190. Epub 2019 Jul 26.
	31152504	0	Lillicrap D, Morrissey JH. 27th ISTH Congress - July in Melbourne. J Thromb Haemost. 2019 Jun;17(6):847. doi: 10.1111/jth.14463.
	31011709	0	Shida Y, Swystun LL, Brown C, et al. Shear stress and platelet-induced tensile forces regulate ADAMTS13-localization within the platelet thrombus. Res Pract Thromb Haemost. 2019 Mar 23;3(2):254-260. doi: 10.1002/rth2.12196. eCollection 2019 Apr.
	30046746	0	Bergmeier W, Antoniak S, Conway EM, et al. Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis. Res Pract Thromb Haemost. 2018 Apr 12;2(3):407-428. doi: 10.1002/rth2.12095. eCollection 2018 Jul.
	28829426	0	Michels A, Swystun LL, Mewburn J, et al. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation. J Vis Exp. 2017 Aug 14;(126). doi: 10.3791/55917.
	28808146	0	Lillicrap D. Thrombolytic Potential of N-Acetylcysteine: Evidence for Significant Benefit in Mitigating Arterial Thrombosis. Circulation. 2017 Aug 15;136(7):661-663. doi: 10.1161/CIRCULATIONAHA.117.029313.
	26862110	0	Flood VH, Christopherson PA, Gill JC, et al. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. Blood. 2016 May 19;127(20):2481-8. doi: 10.1182/blood-2015-10-673681. Epub 2016 Feb 9.
	26149009	0	Lillicrap D, Douketis J. Journal of Thrombosis and Haemostasis. Special Issue: State of the Art 2015. Preface. J Thromb Haemost. 2015 Jun;13 Suppl 1:S1. doi: 10.1111/jth.12979.